Atlas Trials

Study to Assess the Safety and the Phosphate Binding Capacity of Renazorb

Clinical trial NCT01560884 · COMPLETED

Trial details

NCT number
NCT01560884
Sponsor
Spectrum Pharmaceuticals, Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
SafetyPhosphate Binding Capacity
Start date
2012-04-01
Primary completion
2012-09-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.